Curing Seniors’ Hepatitis C Early Could Cut Medicare Costs, Save Lives
Curing hepatitis C before senior citizens age into Medicare could save tens of thousands of lives. And as a new study from Milliman reports, it could also save the Medicare system $3.9 billion over 10 years.
ASCO Value Framework Sparks Dialogue on Patient-centered Care
With cancer care costs poised to reach $158 billion by 2020, the American Society of Clinical Oncology wants to aid physicians and patients in evaluating care options.
AfPA Releases “Understanding Step Therapy” Video
Step therapy, or “fail first,” does what it sounds like, explains a new video from the Alliance for Patient Access.
Medicare Coverage for Abuse-deterrent Opioids Dips, Despite Pills’ Effectiveness
New research suggests that pain pills designed to deter abuse can in fact help curb prescription drug overdoses.
IfPA White Paper Explores Patient Access to Hepatitis C Cures
New cures have stirred high hopes for the millions of Americans infected with hepatitis C.
New Study Questions Medicaid Rationing of Hepatitis C Cures
A new study published in the Annals of Internal Medicine raises a provocative question about hepatitis C care: Does state rationing of new cures violate federal Medicaid law? The study, released June 30, examines which states limit Medicaid patients’ access to the hepatitis C cure sofosbuvir.
“Pain Matters” Encourages Dialogue on Rx Abuse
Talking about prescription opioid abuse can be difficult—especially if you’re one of the millions of Americans living with a legitimate medical need for prescription pain medication.
“Preemie Matters” Summit Raises Profile for Infant Health Issues
Perinatal health care providers, members of Congress, a nationally recognized CNN anchor, advocates and parents all gathered at Washington, DC’s Andrew W. Mellon Auditorium yesterday to voice a unified message: premature infants deserve better access to comprehensive health care.
VA Plan to Outsource Hepatitis C Treatment for Veterans Draws Backlash
The U.S. Department of Veterans Affairs may soon join the ranks of entities curbing patient access in an attempt to balance the budget.
WHO Faces Challenge to Develop Simple Solution to Complex Issue of Naming
On behalf of the Global Alliance for Patient Access I participated in this week’s International Nonproprietary Names (INN) Biological Qualifier (BQ) Comments Review: Front Page Meeting with Stakeholders, held at the World Health Organization Headquarters in Geneva, Switzerland.
